EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of nuclear unrest and p53 immunostaining in Wilms’ tumor

Asmaa Salama, Ahmad Kamel

Journal of the Egyptian National Cancer Institute · 2011

DOI: 10.1016/j.jnci.2011.07.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Egyptian National Cancer Institute, 2011. Verfasst von Asmaa Salama und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, National Cancer Institute, Cairo University, Cairo, Egypt. almadina.salama@gmail.com. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Nuclear unrest is a term applied to Wilms' tumors (WT) that show nuclear abnormalities close to anaplasia but without abnormal mitoses. p53 is claimed to be associated with anaplasia and poor prognosis. This study was undertaken to evaluate the clinical significance of nuclear unrest and p53 immunostaining in Wilms' tumor. MATERIAL AND METHODS: This is a retrospective study of 63 patients who presented at NCI with Wilms' tumors, and underwent preoperative chemotherapy followed by nephrectomy. Histopathologic assessment and p53 immunohistochemistry were done. RESULTS: WT with nuclear unrest grade III closely resembled anaplastic tumors and both of them (group 1) constituted 19% of cases. Group 1 constituted 29% of cases showing blastema dominant morphology compared to 9.4% of cases without blastema dominant morphology with significant statistical difference (p=0.047). Almost 83% of cases that achieved 1st complete remission were stages I, II and III, while 17% were stages IV and V with significant statistical difference (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnaplasiaCell NucleusChildChild, PreschoolCombined Modality TherapyDisease-Free SurvivalFemaleHumansImmunohistochemistryInfantKaplan-Meier EstimateKidneyKidney NeoplasmsMaleNeoplasm StagingPrognosisRetrospective StudiesRisk FactorsTreatment OutcomeTumor Suppressor Protein p53

Substanzen

TP53 protein, humanTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Pathology, National Cancer Institute, Cairo University, Cairo, Egypt. almadina.salama@gmail.com

Zitieren

APA

Salama, A., & Kamel, A. (2011). Evaluation of nuclear unrest and p53 immunostaining in Wilms’ tumor. Journal of the Egyptian National Cancer Institute. https://doi.org/10.1016/j.jnci.2011.07.005

Vancouver

Salama A, Kamel A. Evaluation of nuclear unrest and p53 immunostaining in Wilms’ tumor. Journal of the Egyptian National Cancer Institute. 2011. doi:10.1016/j.jnci.2011.07.005

BibTeX
@article{Salama2011,
  author = {Salama, Asmaa and Kamel, Ahmad},
  title = {Evaluation of nuclear unrest and p53 immunostaining in Wilms’ tumor},
  journal = {Journal of the Egyptian National Cancer Institute},
  year = {2011},
  doi = {10.1016/j.jnci.2011.07.005}
}
Kostenlos starten →